Companies: 10,795·Total market cap: $144.5T
Eli Lilly and Company

Eli Lilly and Company

LLY.TOTSXHealthcare● Active
$40.68
+$0.22(+0.54%)
Market Cap$1.40T
P/E Ratio—
52W High$41.89
52W Low$30.67
Overview

Eli Lilly and Company (LLY.TO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LLY.TO · earnings · updated Jun 8, 2026

No earnings history available.

Next Earnings Date

Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.49B
No earnings history available.
No analyst estimates available for LLY.TO.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: LLY.TO ends December

Eli Lilly and Company (LLY.TO) reports earnings quarterly as a TSX-listed Medical - Pharmaceuticals company. The next LLY.TO earnings date is expected around September 1, 2026.

Each quarter, investors track LLY.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LLY.TO revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LLY.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

LLY.TO earnings · 3 questions

Eli Lilly and Company's next earnings report is expected around September 1, 2026. LLY.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LLY.TO historically reports after market close (AMC).

LLY.TO earnings datewhen is LLY.TO earningsLLY.TO next earnings datewhen does LLY.TO report earningsLLY.TO earnings calendar

▸ Source: FMP · Eli Lilly and Company SEC filings · US GAAP · Eli Lilly and Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026